Back

Underlying driving forces of the SARS-CoV-2 evolution: immune evasion and ACE2 binding affinity

Ma, W.; Fu, H.; Jian, F.; Cao, Y.; Li, M.

2023-02-07 pathology
10.1101/2023.02.06.527236 bioRxiv
Show abstract

The evolution of SARS-CoV-2 is characterized by the emergence of new variants with a sheer number of mutations compared to their predecessors, which conferred resistance to pre-existing antibodies and/or increased transmissibility. The recently emerged Omicron subvariants also exhibit a strong tendency for immune evasion, suggesting adaptive evolution. However, previous studies have been limited to specific lineages or subsets of mutations, the overall evolutionary trajectory of SARS-CoV-2 and the underlying driving forces are still not fully understood. In this study, we analyzed the mutations present in all open-access SARS-CoV-2 genomes (until November 2022) and correlated the mutations incidence and fitness change with its impact on immune evasion and ACE2 binding affinity. Our results showed that the Omicron lineage had an accelerated mutation rate in the RBD region, while the mutation incidence in other genomic regions did not change dramatically over time. Moreover, mutations in the RBD region (but not in any other genomic regions) exhibited a lineage-specific pattern and tended to become more aggregated over time, and the mutation incidence was positively correlated with the strength of antibody pressure on the specific position. Additionally, the incidence of mutation was also positively correlated with changes in ACE2 binding affinity, but with a lower correlation coefficient than with immune evasion. In contrast, the mutations effect on fitness was more closely correlated with changes in ACE2 binding affinity than immune evasion. In conclusion, our results suggest that immune evasion and ACE2 binding affinity play significant and diverse roles in the evolution of SARS-CoV-2.

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Cell Discovery
57 papers in training set
Top 0.1%
37.7%
2
National Science Review
21 papers in training set
Top 0.1%
12.1%
3
Protein & Cell
25 papers in training set
Top 0.1%
6.4%
50% of probability mass above
4
Science Bulletin
21 papers in training set
Top 0.1%
5.2%
5
Cell Reports
1498 papers in training set
Top 7%
5.2%
6
iScience
1154 papers in training set
Top 2%
5.2%
7
PLOS Pathogens
820 papers in training set
Top 4%
3.9%
8
Nature Communications
5641 papers in training set
Top 34%
3.3%
9
eLife
5828 papers in training set
Top 39%
2.6%
10
mBio
833 papers in training set
Top 7%
1.8%
11
Cell Host & Microbe
116 papers in training set
Top 1%
1.6%
12
Journal of Medical Virology
140 papers in training set
Top 2%
1.6%
13
Communications Biology
993 papers in training set
Top 20%
1.3%
14
Microbiology Spectrum
469 papers in training set
Top 9%
0.9%
15
Journal of Virology
499 papers in training set
Top 3%
0.9%
16
Genomics, Proteomics & Bioinformatics
172 papers in training set
Top 2%
0.9%
17
Viruses
332 papers in training set
Top 5%
0.8%
18
Molecular Systems Biology
162 papers in training set
Top 4%
0.6%
19
Scientific Reports
3612 papers in training set
Top 80%
0.6%
20
Science Advances
1243 papers in training set
Top 34%
0.6%
21
Frontiers in Microbiology
427 papers in training set
Top 10%
0.6%
22
PLOS ONE
5266 papers in training set
Top 66%
0.6%
23
PNAS Nexus
159 papers in training set
Top 5%
0.6%